Laparoscopic duodenojejunostomy for superior mesenteric artery syndrome
Chinnusamy Palanivelu1, Muthukumaran Rangarajan, Rangaswamy Senthilkumar
1GEM Hospital, Ramnathapuram, Coimbatore, India.
Summary
Superior mesenteric artery syndrome, a rare condition, can be effectively treated with laparoscopic duodenojejunostomy. This minimally invasive approach offers a highly successful surgical option for chronic cases.
Area of Science:
- Gastroenterology and Surgical Innovation
Background:
- Superior mesenteric artery (SMA) syndrome, also known as Wilkie's syndrome, is a rare gastrovascular disorder.
- Characterized by chronic or acute symptoms, most commonly vomiting, with approximately 15 identified causal factors.
- While conservative management is standard for acute presentations, surgery is reserved for chronic cases or treatment failures, with limited prior laparoscopic interventions.
Observation:
- This report details the ninth case of SMA syndrome managed surgically via laparoscopic duodenojejunostomy.
- The patient, a 14-year-old male, presented with chronic symptoms persisting since childhood.
- The laparoscopic procedure was successfully performed, highlighting its feasibility in managing this rare condition.
Findings:
- Laparoscopic duodenojejunostomy is presented as a highly effective surgical solution for SMA syndrome, demonstrating a 90% success rate.
- Duodenojejunostomy is identified as the preferred surgical procedure, with laparoscopic severing of Treitz's ligament noted as an alternative surgical option.
- Gastrojejunostomy is deemed ineffective for treating SMA syndrome, and conservative management is only beneficial for acute cases.
Implications:
- The findings underscore the efficacy and potential of laparoscopic duodenojejunostomy as a primary surgical intervention for SMA syndrome.
- This case contributes to the limited but growing evidence supporting minimally invasive surgical techniques for SMA syndrome.
- The successful laparoscopic management of this rare condition suggests a promising avenue for improved patient outcomes and reduced surgical morbidity.

